MIG
TBIO

McGuire Investment Group’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

McGuire Investment Group’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-24,784
Closed -$457K – 112
2020
Q4 		$457K Buy
24,784
+8,035
+48% +$144K 0.11% 73
2020
Q3 		$228K Buy
16,749
+6,599
+65% +$102K 0.07% 89
2020
Q2 		$182K Hold
10,150
– – 0.06% 85
2020
Q1 		$101K Hold
10,150
– – 0.04% 80
2019
Q4 		$83K Hold
10,150
– – 0.02% 91
2019
Q3 		$101K Buy
+10,150
New +$95.8K 0.03% 96

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return

McGuire Investment Group's TBIO Position: Q1 2021 in Review

McGuire Investment Group sold out of Translate Bio, Inc. Common Stock (TBIO) in Q1 2021, closing a stake of 24,784 shares — an estimated $457K sold.

McGuire Investment Group first reported a position in TBIO in Q3 2019 and held it in 6 quarters. The position peaked at $457K in Q4 2020. 146 funds tracked by Wall St. Rank hold TBIO as of Q1 2021.

  • McGuire Investment Group reported no remaining Translate Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • McGuire Investment Group sold 24,784 Translate Bio, Inc. Common Stock shares in Q1 2021, an estimated $457K.
  • McGuire Investment Group first reported a position in Translate Bio, Inc. Common Stock in Q3 2019 and held it in 6 quarters.
  • McGuire Investment Group's Translate Bio, Inc. Common Stock position peaked at $457K in Q4 2020.
  • 146 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q1 2021.

Based on McGuire Investment Group's 13F filing for Q1 2021, filed 20 Apr 2021.